CD4+Foxp3E2+ regulatory T cell frequency predicts breast cancer prognosis and recurrence
Clorinda Fusco, Francesca Di Rella, Antonietta Liotti, Alessandra Colamatteo, Anne Lise Ferrara, Vincenzo Gigantino, Francesca Collina, Emanuela Esposito, Ivana Donzelli, Antonio Porcellini, Antonia Feola, Teresa Micillo, Francesco Perna, Federica Garziano, Giorgia Teresa Maniscalco, , Veronica De Rosa
The paper identifies Foxp3E2+ regulatory T cells as a prognostic biomarker for breast cancer recurrence and immune suppression.
Science Advances · Jan 15, 2025Peer-reviewedImmunology